Related Experiment Video

Updated: Aug 19, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Fulminant hepatic failure: Wilson's disease or autoimmune hepatitis? Implications for transplantation

R G Santos1, F Alissa, J Reyes

  • 1Department of Transplant Surgery, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, USA.

Pediatric Transplantation
|January 26, 2005
PubMed

Insights

Diagnosing Wilson's disease (WD) and autoimmune hepatitis (AIH) in pediatric patients with fulminant hepatic failure (FHF) is challenging. This case highlights successful liver transplantation before definitive WD diagnosis, crucial for FHF management.

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Transplantation Medicine

Background:

  • Fulminant hepatic failure (FHF) is a critical condition in children, often necessitating liver transplantation.
  • Wilson's disease (WD) and autoimmune hepatitis (AIH) can present initially as FHF in adolescents.
  • Timely diagnosis is vital as treatments and prognoses for WD and AIH differ significantly.

Observation:

  • A previously asymptomatic adolescent presented with FHF.
  • Clinical and laboratory findings were suggestive of both WD and AIH.
  • Liver transplantation was performed before a definitive diagnosis of WD was established.

Findings:

  • The patient underwent successful therapeutic liver transplantation.
  • The case underscores the diagnostic challenges in differentiating WD and AIH during FHF.
  • Early intervention, including transplantation, may be life-saving even with diagnostic uncertainty.

Implications:

  • This case emphasizes the need for prompt decision-making in FHF management, balancing diagnostic efforts with urgent therapeutic needs.
  • It highlights the critical role of liver transplantation in managing FHF when WD is suspected but unconfirmed.
  • Further research into early diagnostic markers for WD and AIH in FHF is warranted.

More Related Videos

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice11:24

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...